Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anti-Rheumatics
Research findings from Oregon Health & Science University, Division of Infectious Diseases update understanding of anti-rheumatics
March 2nd, 2007
A report, "Serious infections with antirheumatic therapy: are biologicals worse," is newly published data in Annals of the Rheumatic Diseases. "This paper reviews the current evidence for the role of antirheumatic therapy in the development of serious infections in patients with rheumatoid arthritis (RA). Prednisone is clearly associated with increased infectious risk, but no definitive data link methotrexate to infection," researchers in the United States report. "Emerging data suggest that biological agents also pose increase infectious risk, particularly when used in combination with corticosteroids or methotrexate. Further research is needed in this important aspect...
Source: Drug Week (2007-03-02)
|
